Japanese researchers receive SNMMI fellowship
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announced...Read more on AuntMinnie.comRelated Reading: Medical groups back more patient time, less paperwork SNMMI letter urges FDA to ease shortage of gallium-68 SNMMI awards technologists Support urged for funding for U.S. Mo-99 supply SNMMI touts JNM's rising impact factor (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 20, 2018 Category: Radiology Source Type: news

SNMMI 2018-2020 Wagner-Torizuka Fellowship recipients announced
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce the recipients of the 2018-2020 SNMMI Wagner-Torizuka Fellowship. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2018 Category: International Medicine & Public Health Source Type: news

Report: Australia still importing technetium generators
Australia is still importing technetium generators for nuclear medicine studies,...Read more on AuntMinnie.comRelated Reading: ANSTO offers virtual reality tours of OPAL reactor Australian reactor to resume Mo-99 shipments this week Australian agency orders review of Mo-99 procedures Support urged for funding for U.S. Mo-99 supply Australian reactor woes worry nuclear medicine (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 7, 2018 Category: Radiology Source Type: news

Researchers identify pitfall in popular prostate cancer PET imaging method
(Society of Nuclear Medicine and Molecular Imaging) Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging has become a popular method for determining the stage of a patient's prostate cancer. However, researchers have identified a major pitfall in this imaging technique and are cautioning medical professionals to be aware of the potential for misdiagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2018 Category: International Medicine & Public Health Source Type: news

New nuclear medicine imaging method shows strong potential for cancer imaging
(Society of Nuclear Medicine and Molecular Imaging) A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 5, 2018 Category: International Medicine & Public Health Source Type: news

Nuclear medicine conference comes to Jordan
The latest diagnostic and therapeutic applications of nuclear medicine in cancer...Read more on AuntMinnie.comRelated Reading: Open SESAME: Jordan's bold experiment puts science first Philips to partner with cancer center in Jordan (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 4, 2018 Category: Radiology Source Type: news

RadioMedix, Curium ink deal on new PET agent
Global nuclear medicine firm Curium and biotechnology firm RadioMedix have...Read more on AuntMinnie.comRelated Reading: RadioMedix, ITM ink radiopharmaceutical generator deal Curium to market xenon-133 gas in the U.S. Curium switches Mo-99 production process to LEU IBA Molecular forms Curium as new radiopharmacy player (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 28, 2018 Category: Radiology Source Type: news

ANSTO offers virtual reality tours of OPAL reactor
Want to tour a nuclear reactor from the comfort of your home or office? The...Read more on AuntMinnie.comRelated Reading: Australian reactor to resume Mo-99 shipments this week Australian agency orders review of Mo-99 procedures Australian reactor woes worry nuclear medicine Australia needs space for radioactive waste Australian project to boost world Mo-99 supply (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 16, 2018 Category: Radiology Source Type: news

SNMMI letter urges FDA to ease shortage of gallium-68
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has written a...Read more on AuntMinnie.comRelated Reading: SNMMI awards technologists SNMMI touts JNM's rising impact factor SNMMI: New therapy aids patients with neuroendocrine tumors SNMMI announces new officers for 2018-2019 SNMMI schedules training forum for annual meeting (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 15, 2018 Category: Radiology Source Type: news

Nuclear medicine duties not always shared equally
What's in a name? Apparently a lot when it comes to nuclear medicine. Physicians...Read more on AuntMinnie.comRelated Reading: Live from SNMMI 2018: Nuclear medicine and patients SNMMI 2018: A year of promotion and ongoing challenges Radiology extenders improve workflow, job satisfaction Study tracks radiation dose to NM technologists Nuclear medicine techs have higher risk of cataracts (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 14, 2018 Category: Radiology Source Type: news

SNMMI honors outstanding contributors at 2018 annual meeting
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2018 Annual Meeting in Philadelphia. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 13, 2018 Category: International Medicine & Public Health Source Type: news

ARTMS ’ system may ease cost, shortage of valuable radioisotopes
ARTMS Products (Vancouver, B.C) has won the CE mark for its first-in-class, advanced technology Quantm irradiation system, designed to produce high-value medical imaging isotopes such as technetium-99m (Tc-99m) on medical cyclotrons. Tc-99m is given to nearly 50,000 Americans every day to diagnose cancer and heart disease. It is used in more than 80% of all nuclear medicine imaging procedures globally, including those for oncology, urology and neurology. The light-emitting isotope is made by bombarding Molybendum-99 (moly-99) with neutrons. The temporary shutdown of two reactors that produced moly-99 led to a global s...
Source: Mass Device - August 8, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Diagnostics Imaging Neurological Oncology Regulatory/Compliance Urology artms CE Mark Shine Medical Technology Source Type: news

Australian reactor to resume Mo-99 shipments this week
Shipments of the key radioisotope molybdenum-99 (Mo-99) should begin again...Read more on AuntMinnie.comRelated Reading: Australian agency orders review of Mo-99 procedures Support urged for funding for U.S. Mo-99 supply Australian reactor woes worry nuclear medicine Live from SNMMI 2018: Update on radiopharmaceuticals Can nuclear medicine avoid another Mo-99 shortage? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2018 Category: Radiology Source Type: news

PET tracer identifies estrogen receptor expression differences in breast cancer patients
(Society of Nuclear Medicine and Molecular Imaging) In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the metastases. However, little is known about ER expression across metastases throughout the body and surrounding normal tissue. Using a PET tracer, researchers in the Netherlands have been able to identify differences in ER expression, which could help guide treatment for metastatic breast cancer patients. The study is featured in The Journal of Nuclear Medicine's August issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Drug shortage puts PET, SPECT stress to the test
Nuclear medicine facilities are again relying on their improvisational skills...Read more on AuntMinnie.comRelated Reading: FDA warns of risks with Lexiscan, Adenoscan stress agents Regadenoson with Rb-82 PET MPI helps detect obstructive CAD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 3, 2018 Category: Radiology Source Type: news

Novel PET imaging method could track and guide therapy for type 1 diabetes
This study is reported in the featured article of the month in The Journal of Nuclear Medicine's August issue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2018 Category: International Medicine & Public Health Source Type: news

SNMMI awards technologists
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held several...Read more on AuntMinnie.comRelated Reading: SNMMI touts JNM's rising impact factor SNMMI 2018: Theranostic agent awarded Image of the Year SNMMI: AI enables stress-first SPECT MPI protocol SNMMI announces new officers for 2018-2019 SNMMI schedules training forum for annual meeting (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 30, 2018 Category: Radiology Source Type: news

Global nuclear medicine groups chart the future
A weeklong meeting of nuclear medicine societies and organizations from around...Read more on AuntMinnie.comRelated Reading: SNMMI, IAEA collaborate on training ESR, IAEA partner to advance imaging IAEA debuts radiotherapy patient safety tool IAEA: Doctors don't always follow guidelines for pediatric CT UN's IAEA launches pediatric rad therapy network (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 30, 2018 Category: Radiology Source Type: news

SNMMI Technologist Section announces 2018 award winners
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging's Technologist Section (SNMMI-TS)--an international scientific and medical organization--recognized contributions to and work in the field of nuclear medicine and molecular imaging during the SNMMI 2018 Annual Meeting in Philadelphia, held June 23-26. Several awards ceremonies were held to recognize the valuable role that SNMMI-TS members play in advancing the discipline of nuclear medicine technology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 30, 2018 Category: International Medicine & Public Health Source Type: news

Russia, South Africa partner on radioisotope deal
Russian atomic energy firm Rosatom and Nuclear Energy Corp. of South Africa...Read more on AuntMinnie.comRelated Reading: NTP execs return to work after inquiry Can nuclear medicine avoid another Mo-99 shortage? South African facility resumes Mo-99 production South African Mo-99 maker completes LEU conversion Report warns of shortages to Mo-99 supply in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 27, 2018 Category: Radiology Source Type: news

Australian agency orders review of Mo-99 procedures
An Australian government agency has ordered a review of radiation safety procedures...Read more on AuntMinnie.comRelated Reading: Support urged for funding for U.S. Mo-99 supply Australian reactor woes worry nuclear medicine Live from SNMMI 2018: Update on radiopharmaceuticals Live from SNMMI 2018: Securing the molybdenum supply Can nuclear medicine avoid another Mo-99 shortage? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 20, 2018 Category: Radiology Source Type: news

SNMMI touts JNM's rising impact factor
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is highlighting...Read more on AuntMinnie.comRelated Reading: SNMMI announces new officers for 2018-2019 SNMMI 2018: A year of promotion and ongoing challenges SNMMI schedules training forum for annual meeting SNMMI offers open access option for JNM SNMMI seeks to boost molecular imaging's value (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 19, 2018 Category: Radiology Source Type: news

Support urged for funding for U.S. Mo-99 supply
A consortium of radiology associations, patient advocacy groups, and radiology...Read more on AuntMinnie.comRelated Reading: Australian reactor woes worry nuclear medicine Can nuclear medicine avoid another Mo-99 shortage? FDA, NRC clear path for U.S. supply of molybdenum-99 SNMMI pushes Congress for U.S.-based Mo-99 supply Report warns of shortages to Mo-99 supply in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 19, 2018 Category: Radiology Source Type: news

The Journal of Nuclear Medicine impact factor increases by 12 percent
(Society of Nuclear Medicine and Molecular Imaging) The Journal of Nuclear Medicine (JNM)--the flagship publication of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)--has again been ranked among the top medical imaging journals worldwide, according to new data released in the 2017 Journal Citation Reports © published by Clarivate Analytics. JNM's impact factor went up from 6.646 (2016) to 7.439 (2017). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 18, 2018 Category: International Medicine & Public Health Source Type: news

NTP execs return to work after inquiry
Three senior executives at South African radioisotope firm NTP Radioisotopes...Read more on AuntMinnie.comRelated Reading: Can nuclear medicine avoid another Mo-99 shortage? South African facility resumes Mo-99 production South African Mo-99 maker completes LEU conversion NTP temporarily halts Mo-99 production South African reactor starts moly production (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2018 Category: Radiology Source Type: news

Time-of-flight PET can reduce radiation dose in pediatrics
By adding a time-of-flight technique to pediatric PET scans, clinicians can...Read more on AuntMinnie.comRelated Reading: Study tracks radiation dose to NM technologists Artificial intelligence guides lower PET tracer dose FDA guidance urges lower radiation dose for kids SNMMI: Education eases patients' nuclear medicine fears Radiation exposure monitoring needs a personal touch (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 9, 2018 Category: Radiology Source Type: news

Australian reactor woes worry nuclear medicine
The shutdown of shipments from a nuclear reactor in Australia that is a key...Read more on AuntMinnie.comRelated Reading: Live from SNMMI 2018: Update on radiopharmaceuticals Live from SNMMI 2018: Securing the molybdenum supply Can nuclear medicine avoid another Mo-99 shortage? Canada's NRU reactor to go offline for the final time NorthStar's novel generator could relieve U.S. isotope shortages (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 6, 2018 Category: Radiology Source Type: news

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise
(Society of Nuclear Medicine and Molecular Imaging) In a mouse model, researchers have demonstrated that a novel, affibody-based pretargeted radionuclide therapy for HER2 (human epidermal growth factor receptor 2)-expressing cancers is non-toxic to the kidneys and improves survival. The study is reported in The Journal of Nuclear Medicine's July featured article of the month. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2018 Category: Cancer & Oncology Source Type: news

SNMMI 65th Annual Meeting sets the stage for a revolution in precision medicine
(Society of Nuclear Medicine and Molecular Imaging) More than 5,000 physicians, technologists, scientists and exhibitors gathered for the Society of Nuclear Medicine and Molecular Imaging's 65th Annual Meeting, held June 23-26 in Philadelphia. With nuclear medicine playing a growing role in providing precision medicine, theranostics (combining diagnostic imaging and targeted radionuclide therapy) were an important focus throughout the meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2018 Category: International Medicine & Public Health Source Type: news

Fault at Lucas Heights nuclear reactor halts production of medical isotope
Spokesman says no safety risk but there are fears patients could face delays in cancer diagnosisPatients in hospitals around Australia may face delays in cancer diagnosis after production of the most commonly used isotope in nuclear medicine was halted at the Lucas Heights nuclear reactor in Sydney ’s south.The Australian Nuclear Science and Technology Organisation (Ansto) usually produces about 10,000 doses a week of Technetium-99m (Tc-99m), which is used to diagnose a variety of heart, lung and musculoskeletal conditions, as well as cancers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 28, 2018 Category: Science Authors: Guardian staff Tags: Sydney Nuclear power Australia news Medical research Cancer Science Health Source Type: news

Better Imaging for Prostate Cancer Patients?
The objective [of LOCATE] was to access the impact of positron imaging for patient management,” Peter Gardiner, Blue Earth Diagnostics CMO, told MD+DI. “These were men with recurrent prostate cancer.” For the LOCATE trial 213 men with biochemically recurrent prostate cancer were evaluated with 18F-fluciclovine PET/CT after having negative or equivocal findings on conventional imaging, such as a bone scan, CT or MRI. This first prospective multi-center study was conducted at 15 sites in the U.S., including both private practices and academic settings. It focused on the association between scan positivity a...
Source: MDDI - June 27, 2018 Category: Medical Devices Authors: Omar Ford Tags: Imaging Testing Source Type: news

Live from SNMMI 2018: Update on radiopharmaceuticals
What's going on in the world of medical isotopes? From molybdenum supply to...Read more on AuntMinnie.comRelated Reading: Live from SNMMI 2018: Nuclear medicine and patients Live from SNMMI 2018: Securing the molybdenum supply Live from SNMMI 2018: Nuclear medicine appropriate use Live from SIIM 2018: AI and value-based healthcare Live from SIIM 2018: From pen and ink to AI in radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2018 Category: Radiology Source Type: news

Live from SNMMI 2018: Nuclear medicine and patients
Patients justifiably are the centers of attention in imaging procedures, and...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT Live from SNMMI 2018: Securing the molybdenum supply Live from SNMMI 2018: Nuclear medicine appropriate use SNMMI 2018: A year of promotion and ongoing challenges (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2018 Category: Radiology Source Type: news

New radionucleotide therapy effective to treat neuroendocrine tumours
A new study in humans, presented during the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, shows that a new, long-lasting radionucleotide therapy is effective for the treatment of advanced metastatic NETs.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 26, 2018 Category: Endocrinology Source Type: news

Early treatment of advanced prostate cancer with radioligand therapy prolongs life
(Society of Nuclear Medicine and Molecular Imaging) Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates for the first time the benefit of providing earlier lutetium-177 (177Lu) prostate-specific membrane antigen (PSMA) radioligand therapy to patients with metastatic prostate cancer. Until now, this therapy has only been used in patients with end-stage disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Fluciclovine PET/CT locates recurrent prostate cancer and advises management
(Society of Nuclear Medicine and Molecular Imaging) The addition of fluorine-18 (18F)-fluciclovine positron emission tomography/computed tomography (PET/CT) to the diagnostic work-up of patients with biochemical recurrence of prostate cancer locates previously undetected lesions and changes treatment management for the majority of patients, according to a clinical trial report presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

SNMMI image of the year: PSMA PET imaging of theranostic for advanced prostate cancer
(Society of Nuclear Medicine and Molecular Imaging) Studies of patients with metastatic castrate-resistant prostate cancer have demonstrated high response rates to radionuclide therapy targeting PSMA with the radionuclide lutetium-177. At the SNMMI Annual Meeting, researchers reported on a phase II prospective trial. Men who had exhausted conventional therapies were screened using gallium-68-PSMA11 PET imaging. Those with high PSMA-expression had 177Lu-PSMA617 therapy and experienced high response rates, which is clearly shown in the figure selected as the 2018 SNMMI Image of the Year. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2018 Category: International Medicine & Public Health Source Type: news

Society of Nuclear Medicine and Molecular Imaging announces 2018 Fellows
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging recognized 14 new SNMMI Fellows on June 25 during a Special Plenary Session at the society's 2018 Annual Meeting, held June 23-26 in Philadelphia. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is one of the most prestigious formal recognitions available to long-time SNMMI members. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2018 Category: International Medicine & Public Health Source Type: news

Live from SNMMI 2018: Nuclear medicine appropriate use
What's the best way to promote appropriate use of nuclear medicine? Dr. Sukhjeet...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT SNMMI: New therapy aids patients with neuroendocrine tumors SNMMI: AI can predict survival in sarcoma patients Live from SNMMI 2018: Securing the molybdenum supply SNMMI 2018: A year of promotion and ongoing challenges (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

Live from SNMMI 2018: Securing the molybdenum supply
Global efforts are underway to ensure that adequate supplies of molybdenum-99...Read more on AuntMinnie.comRelated Reading: SNMMI 2018: A year of promotion and ongoing challenges Can nuclear medicine avoid another Mo-99 shortage? Canadians create nuclear isotope council Canada's NRU reactor to go offline for the final time NorthStar's novel generator could relieve U.S. isotope shortages (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

SNMMI announces new officers for 2018-2019
PHILADELPHIA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI)...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT SNMMI: New therapy aids patients with neuroendocrine tumors SNMMI 2018: A year of promotion and ongoing challenges SNMMI schedules training forum for annual meeting SNMMI offers open access option for JNM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

New theranostic strategy developed for precise tumor diagnosis and therapy
(Society of Nuclear Medicine and Molecular Imaging) A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging. The research was presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective
(Society of Nuclear Medicine and Molecular Imaging) A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors (NETs). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Novel nuclear medicine approach shows promise for treating wide array of cancerous tumors
(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Sanjiv Sam Gambhir, M.D., Ph.D., receives Benedict Cassen Prize for Molecular Imaging Research
(Society of Nuclear Medicine and Molecular Imaging) Sanjiv Sam Gambhir, M.D., Ph.D., known for his pioneering work in multimodality molecular imaging, was awarded the Benedict Cassen Prize during the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Philadelphia, Pa. This honor is awarded every two years by the Education and Research Foundation for Nuclear Medicine and Molecular Imaging in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

New nuclear medicine technique could help tackle brain disease
(Society of Nuclear Medicine and Molecular Imaging) A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2018 Category: International Medicine & Public Health Source Type: news

Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
(Society of Nuclear Medicine and Molecular Imaging) New nuclear medicine tracers could help medical researchers find a cure for Alzheimer's and other neurodegenerative diseases. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2018 Category: International Medicine & Public Health Source Type: news

Combining targeted radionuclide therapy and immunotherapy could improve melanoma survival
(Society of Nuclear Medicine and Molecular Imaging) Research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows that combining targeted radionuclide therapy with immunotherapy could improve the survival of patients with metastatic melanoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2018 Category: Cancer & Oncology Source Type: news

Richard L. Wahl, M.D., receives SNMMI 2018 Georg Charles de Hevesy Nuclear Pioneer Award
(Society of Nuclear Medicine and Molecular Imaging) Richard L. Wahl, M.D., FACNM, FACR, received this year's Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to nuclear medicine at the Society of Nuclear Medicine and Molecular Imaging's 2018 Annual Meeting, June 23-26 in Philadelphia. Wahl is the Elizabeth E. Mallinckrodt Professor and head of radiology at Washington University School of Medicine in St. Louis, director of the university's Mallinckrodt Institute of Radiology and a professor of radiation oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2018 Category: Cancer & Oncology Source Type: news

Simon Cherry, Ph.D., receives SNMMI 2018 Paul C. Aebersold Award in Nuclear Medicine Science
(Society of Nuclear Medicine and Molecular Imaging) Simon R. Cherry, Ph.D., Distinguished Professor at the University of California, Davis, has been named the 2018 recipient of the prestigious Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science. Cherry was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2018 Category: Cancer & Oncology Source Type: news